Abbott: all 1,345 studies

Page 12 of 14. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart FailureWithdrawnNCT00487799Phase 1
• Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in EuropeCompletedNCT00479921Phase 3
• An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)CompletedNCT00478660Phase 3
• A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent SystemCompletedNCT00475566Not applicable
• Aortic Valve Replacement With Trifecta(TM)CompletedNCT00475267Not applicable
• Efficacy and Safety Study on Agilis NxT Introducer in AF PatientsCompletedNCT00469638Not applicable
• Tolerance and Development of Healthy, Term InfantsCompletedNCT00465764Phase 2
• RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-DCompletedNCT00453622
• The Utility of Ischemia Modified Albumin (IMA) in SepsisCompletedNCT00448968
• A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid ArthritisCompletedNCT00448383Phase 3
• A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol DrinkersCompletedNCT00429468Phase 1
• A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00429091Phase 2
• A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)CompletedNCT00427362Phase 3
• A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract ExtractionTerminatedNCT00425464Phase 3
• Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple MyelomaCompletedNCT00425347Phase 1
• SAFE Study - Septal Pacing for Atrial Fibrillation Suppression EvaluationCompletedNCT00419640Not applicable
• An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of SchizophreniaTerminatedNCT00412620Phase 2
• An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.CompletedNCT00407095Phase 3
• SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsCompletedNCT00406588Phase 3
• CHOICE: Carotid Stenting For High Surgical-Risk PatientsCompletedNCT00406055
• A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy SurgeryCompletedNCT00404391Phase 2
• A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain Following BunionectomyCompletedNCT00404222Phase 2
• A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With OsteoarthritisCompletedNCT00404183Phase 2
• A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following BunionectomyCompletedNCT00402792Phase 3
• A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedNCT00402584Phase 3
• SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in EuropeCompletedNCT00402272Phase 4
• A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine InsufficiencyCompletedNCT00401076Phase 3
• A Study of SA-001 to Treat Pancreatic Exocrine InsufficiencyCompletedNCT00400842Phase 3
• Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsTerminatedNCT00396214Phase 3
• A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00391729Phase 2
• STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?TerminatedNCT00369499Not applicable
• A Study of Volociximab in Metastatic MelanomaTerminatedNCT00369395Phase 2
• STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation TrialCompletedNCT00367757Not applicable
• EVITA: Evaluation of VIP Feature in Pacemaker PatientsCompletedNCT00366158Not applicable
• Comparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinCompletedNCT00362934Phase 3
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOCompletedNCT00362323Phase 3
• Comparison of the Combination of Fenofibrate and Simvastatin Versus PravastatinCompletedNCT00362206Phase 3
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedNCT00361868Phase 3
• The Ischemia Modified Albumin In Diagnosing Ischemic New EventsTerminatedNCT00355992
• A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung CancerTerminatedNCT00354562Phase 1/2
• Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4
• Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and AdolescentsTerminatedNCT00352768Phase 4
• Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00352183Phase 3
• A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNCT00349635Phase 2
• Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00349375Phase 3
• A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic SyndromeCompletedNCT00349284Phase 3
• Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesCompletedNCT00349128Phase 2/3
• Acceptability of a Fixed Combination of Fenofibrate and MetforminCompletedNCT00348725Phase 3
• Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.CompletedNCT00348504Phase 3
• Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
• Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.CompletedNCT00346723Phase 3
• Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.WithdrawnNCT00345462Phase 3
• Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00338754Phase 2/3
• Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)CompletedNCT00338650Phase 3
• An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsCompletedNCT00335374Phase 3
• SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseCompletedNCT00335166Phase 3
• An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsCompletedNCT00332917Phase 3
• Observational Study of Prosthetic Tissue Aortic and Mitral Heart ValveCompletedNCT00329667Not applicable
• A Study of Pain Relief in Low Back PainCompletedNCT00325949Phase 3
• Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in ChinaCompletedNCT00325260Phase 3
• Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)TerminatedNCT00307827Phase 2
• CAPTURE 2 Post-Marketing RegistryCompletedNCT00302237
• ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationCompletedNCT00300131
• A Study of Pain Relief in OsteoarthritisCompletedNCT00298974Phase 3
• Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)CompletedNCT00287508Phase 4
• Frontier Registry II Bifurcation Stent System RegistryWithdrawnNCT00286195Phase 4
• Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) StudyCompletedNCT00281073Phase 1/2
• Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab StudyTerminatedNCT00279435Phase 2/3
• A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative ColitisTerminatedNCT00279422Phase 2/3
• SLV308 for Treatment of Patients With Early Parkinson's DiseaseCompletedNCT00269516Phase 3
• Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's DiseaseCompletedNCT00267722Phase 2
• Visilizumab for Treatment of Perianal Fistulas in Crohn's DiseaseCompletedNCT00267709Phase 2
• ESCAPE Migraine TrialTerminatedNCT00267371Phase 3
• Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative ColitisCompletedNCT00267306Phase 1/2
• Efficacy of Pancrelipase on Postprandial Belching and Bloating.CompletedNCT00266721Phase 3
• Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)CompletedNCT00264225Phase 3
• A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.CompletedNCT00261911Phase 3
• REST Study: Left Ventricular Regression European StudyCompletedNCT00256165Phase 4
• Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing TrialCompletedNCT00256152Phase 4
• Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone CombinationCompletedNCT00251082Phase 3
• A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed EndometriosisCompletedNCT00244452Phase 2
• DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)CompletedNCT00243438
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00237887Phase 3
• Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)CompletedNCT00235885Phase 3
• Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00235859Phase 3
• Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00235820Phase 3
• A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)CompletedNCT00235014Phase 4
• Russian Study of the Efficacy and Safety of Tarka in Patients With HypertensionCompletedNCT00235001Phase 4
• A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.CompletedNCT00234988Phase 4
• Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral TherapyTerminatedNCT00234962Phase 4
• A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin InfectionsCompletedNCT00234949Phase 4
• Quality of Life Study With Adalimumab in Rheumatoid ArthritisCompletedNCT00234936Phase 3
• Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve PatientsCompletedNCT00234923Phase 3
• Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected PatientsCompletedNCT00234910Phase 3
• Efficacy of HUMIRA in Subjects With Active Rheumatoid ArthritisCompletedNCT00234897Phase 4
• Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)CompletedNCT00234871Phase 4
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)CompletedNCT00234858Phase 4
• Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisCompletedNCT00234845Phase 3
• A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid ArthritisCompletedNCT00233571Phase 3

← Abbott overview and focus areas